Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Calcimedica, Inc. (CALC)
since 2020 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Calcimedica, Inc..
Table 2 shows the detailed insider transactions.
This company's CIK number is 1534133.
Total stock buying since 2020: $45,708,052.
Total stock sales since 2020: $32,239.
Total stock option exercises since 2020: $39,297.
Table 3. Detailed insider trading at Calcimedica, Inc. (CALC)
Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
2025-08-29 | Roberts Eric W (CHIEF BUSINESS OFFICER) | Buy | 800 | 2.74 | 2,192 |
2025-08-28 | Roberts Eric W (CHIEF BUSINESS OFFICER) | Buy | 9,200 | 2.86 | 26,339 |
2025-08-21 | Roberts Eric W (CHIEF BUSINESS OFFICER) | Buy | 3,508 | 2.79 | 9,797 |
2025-08-20 | Roberts Eric W (CHIEF BUSINESS OFFICER) | Buy | 2,000 | 2.72 | 5,440 |
2025-08-20 | Roberts Eric W (CHIEF BUSINESS OFFICER) | Option Ex | 15,000 | 1.53 | 22,950 |
2025-08-19 | Hebbar Sudarshan (Chief Medical Officer) | Buy | 9,563 | 2.82 | 26,958 |
2025-08-19 | Roberts Eric W (CHIEF BUSINESS OFFICER) | Buy | 1,000 | 2.79 | 2,790 |
2025-08-15 | Hebbar Sudarshan (Chief Medical Officer) | Buy | 4,392 | 2.79 | 12,266 |
2025-08-15 | Roberts Eric W (CHIEF BUSINESS OFFICER) | Buy | 5,076 | 2.90 | 14,710 |
2025-08-14 | Hebbar Sudarshan (Chief Medical Officer) | Buy | 1,584 | 2.58 | 4,094 |
2025-07-28 | Stauderman Kenneth A. (Chief Scientific Officer) | Buy | 1,000 | 3.96 | 3,960 |
2025-07-25 | Stauderman Kenneth A. (Chief Scientific Officer) | Sale | 1,000 | 3.65 | 3,650 |
2025-07-22 | Roberts Eric W (CHIEF BUSINESS OFFICER) | Buy | 1,500 | 3.77 | 5,662 |
2025-07-21 | Roberts Eric W (CHIEF BUSINESS OFFICER) | Buy | 1,500 | 3.37 | 5,055 |
2025-07-21 | Leheny A. Rachel (CHIEF EXECUTIVE OFFICER) | Buy | 1,000 | 3.40 | 3,400 |
2025-07-18 | Roberts Eric W (CHIEF BUSINESS OFFICER) | Buy | 2,000 | 2.88 | 5,760 |
2025-07-18 | Wilson Robert N | Buy | 4,500 | 2.87 | 12,915 |
2025-07-14 | Roberts Eric W (CHIEF BUSINESS OFFICER) | Buy | 6,500 | 2.43 | 15,808 |
2025-07-14 | Leheny A. Rachel (CHIEF EXECUTIVE OFFICER) | Buy | 2,500 | 2.47 | 6,175 |
2025-07-09 | Roberts Eric W (CHIEF BUSINESS OFFICER) | Buy | 5,000 | 1.60 | 8,025 |
2025-07-01 | Stauderman Kenneth A. (Chief Scientific Officer) | Buy | 1,000 | 1.85 | 1,850 |
2025-06-26 | Bardin Stephen (Chief Financial Officer) | Buy | 2,000 | 1.50 | 3,006 |
2025-06-26 | Roberts Eric W (CHIEF BUSINESS OFFICER) | Buy | 4,500 | 1.44 | 6,484 |
2025-06-11 | Roberts Eric W (CHIEF BUSINESS OFFICER) | Buy | 5,000 | 1.85 | 9,250 |
2025-05-30 | Bardin Stephen (Chief Financial Officer) | Buy | 1,000 | 1.69 | 1,690 |
2024-12-06 | Middleton Fred A | Buy | 4,800 | 2.65 | 12,720 |
2024-11-01 | Sanderling Ventures Management Vii | Buy | 87,744 | 3.75 | 329,040 |
2024-11-01 | Roberts Eric W (CHIEF BUSINESS OFFICER) | Buy | 53,333 | 3.75 | 199,998 |
2024-11-01 | Leheny A. Rachel (CHIEF EXECUTIVE OFFICER) | Buy | 20,000 | 3.75 | 75,000 |
2024-11-01 | Middleton Fred A | Buy | 107,744 | 3.75 | 404,040 |
2024-11-01 | Wilson Robert N | Buy | 53,333 | 3.75 | 199,998 |
2024-09-09 | Dunn Michael J. (President and COO) | Option Ex | 11,761 | 1.39 | 16,347 |
2024-08-27 | Leheny A. Rachel (CHIEF EXECUTIVE OFFICER) | Buy | 1,000 | 4.19 | 4,190 |
2024-08-23 | Roberts Eric W (CHIEF BUSINESS OFFICER) | Buy | 5,000 | 3.57 | 17,870 |
2024-08-23 | Wilson Robert N | Buy | 54,000 | 3.72 | 200,826 |
2024-08-21 | Roberts Eric W (CHIEF BUSINESS OFFICER) | Buy | 5,000 | 4.04 | 20,200 |
2024-06-28 | Wilson Robert N | Buy | 51,278 | 3.52 | 180,498 |
2024-06-27 | Roberts Eric W (CHIEF BUSINESS OFFICER) | Buy | 5,000 | 3.22 | 16,100 |
2024-06-27 | Wilson Robert N | Buy | 8,443 | 3.23 | 27,304 |
2024-04-02 | Roberts Eric W (CHIEF BUSINESS OFFICER) | Buy | 3,254 | 3.90 | 12,690 |
2024-04-01 | Roberts Eric W (CHIEF BUSINESS OFFICER) | Buy | 746 | 3.90 | 2,909 |
2024-01-23 | Sanderling Ventures Management Vii | Buy | 679,384 | 3.70 | 2,515,079 |
2024-01-23 | Middleton Fred A | Buy | 679,384 | 3.70 | 2,515,079 |
2023-12-11 | Wilson Robert N (Director) | Buy | 506 | 3.30 | 1,669 |
2023-11-07 | Leheny A. Rachel (Chief Executive Officer) | Buy | 2,000 | 3.34 | 6,680 |
2023-11-06 | Roberts Eric W (Chief Business Officer) | Buy | 2,400 | 3.12 | 7,488 |
2023-11-06 | Leheny A. Rachel (Chief Executive Officer) | Buy | 2,440 | 3.12 | 7,615 |
2023-11-03 | Hebbar Sudarshan (Chief Medical Officer) | Buy | 36,000 | 2.74 | 98,604 |
2023-11-03 | Roberts Eric W (Chief Business Officer) | Buy | 24,009 | 2.78 | 66,787 |
2023-11-03 | Leheny A. Rachel (Chief Executive Officer) | Buy | 5,000 | 2.85 | 14,250 |
2023-08-25 | Roberts Eric W (Chief Business Officer) | Buy | 736 | 3.18 | 2,340 |
2023-08-22 | Roberts Eric W (Chief Business Officer) | Buy | 714 | 3.27 | 2,334 |
2023-08-21 | Roberts Eric W (Chief Business Officer) | Buy | 1,750 | 3.25 | 5,687 |
2023-06-26 | Roberts Eric W (Chief Business Officer) | Buy | 1,400 | 3.62 | 5,062 |
2023-06-23 | Roberts Eric W (Chief Business Officer) | Buy | 500 | 3.35 | 1,675 |
2023-06-21 | Roberts Eric W (Chief Business Officer) | Buy | 2,000 | 4.12 | 8,250 |
2023-06-20 | Roberts Eric W (Chief Business Officer) | Buy | 500 | 4.85 | 2,425 |
2023-06-09 | Leheny A. Rachel (Chief Executive Officer) | Buy | 400 | 5.25 | 2,100 |
2023-06-09 | Middleton Fred A (Director) | Buy | 714 | 5.20 | 3,712 |
2023-06-08 | Roberts Eric W (Chief Business Officer) | Buy | 485 | 5.20 | 2,522 |
2023-06-08 | Leheny A. Rachel (Chief Executive Officer) | Buy | 928 | 5.23 | 4,850 |
2023-06-07 | Roberts Eric W (Chief Business Officer) | Buy | 1,500 | 5.23 | 7,840 |
2023-06-07 | Leheny A. Rachel (Chief Executive Officer) | Buy | 1,000 | 5.25 | 5,248 |
2023-06-07 | Middleton Fred A (Director) | Buy | 500 | 5.20 | 2,600 |
2023-06-06 | Roberts Eric W (Chief Business Officer) | Buy | 3,200 | 5.09 | 16,278 |
2023-06-06 | Leheny A. Rachel (Chief Executive Officer) | Buy | 1,000 | 5.13 | 5,129 |
2023-06-06 | Middleton Fred A (Director) | Buy | 500 | 4.88 | 2,440 |
2023-06-02 | Roberts Eric W (Chief Business Officer) | Buy | 1,687 | 4.90 | 8,266 |
2023-06-02 | Leheny A. Rachel (Chief Executive Officer) | Buy | 1,000 | 4.80 | 4,800 |
2023-06-01 | Roberts Eric W (Chief Business Officer) | Buy | 2,000 | 4.42 | 8,830 |
2023-05-31 | Leheny A. Rachel (Chief Executive Officer) | Buy | 1,000 | 4.21 | 4,210 |
2023-05-31 | Bjerkholt Eric (Director) | Buy | 250 | 4.14 | 1,036 |
2023-05-30 | Roberts Eric W (Chief Business Officer) | Buy | 2,000 | 3.86 | 7,724 |
2023-05-30 | Bjerkholt Eric (Director) | Buy | 5 | 3.25 | 16 |
2023-05-23 | Roberts Eric W (Chief Business Officer) | Buy | 2,000 | 3.26 | 6,526 |
2023-05-23 | Leheny A. Rachel (Chief Executive Officer) | Buy | 3,000 | 3.34 | 10,032 |
2023-05-23 | Bjerkholt Eric (Director) | Buy | 500 | 3.27 | 1,634 |
2023-05-22 | Roberts Eric W (Chief Business Officer) | Buy | 6,000 | 2.95 | 17,700 |
2023-05-19 | Middleton Fred A (Director) | Buy | 10,000 | 2.85 | 28,500 |
2023-05-19 | Bjerkholt Eric (Director) | Buy | 199 | 2.65 | 527 |
2023-05-18 | Bjerkholt Eric (Director) | Buy | 301 | 2.67 | 812 |
2023-05-17 | Roberts Eric W (Chief Business Officer) | Buy | 3,000 | 2.68 | 8,040 |
2023-05-17 | Bjerkholt Eric (Director) | Buy | 200 | 2.67 | 534 |
2023-05-16 | Hebbar Sudarshan (Chief Medical Officer) | Buy | 10,000 | 2.70 | 27,000 |
2023-05-16 | Roberts Eric W (Chief Business Officer) | Buy | 5,300 | 2.71 | 14,389 |
2023-05-16 | Leheny A. Rachel (Chief Executive Officer) | Buy | 1,000 | 2.69 | 2,690 |
2023-05-16 | Bjerkholt Eric (Director) | Buy | 800 | 2.70 | 2,160 |
2023-03-14 | Breuil Robert S (Chief Financial Officer) | Option Ex | 5,000 | .00 | 0 |
2023-03-03 | Guerard Frederic (Chief Executive Officer) | Option Ex | 315,496 | .00 | 0 |
2023-03-03 | Zamiri Parisa (Chief Medical Officer) | Option Ex | 120,655 | .00 | 0 |
2023-03-03 | Breuil Robert S (Chief Financial Officer) | Option Ex | 121,217 | .00 | 0 |
2022-12-12 | Breuil Robert S (Chief Financial Officer) | Option Ex | 5,000 | .00 | 0 |
2022-12-01 | Guerard Frederic (Chief Executive Officer) | Option Ex | 28,125 | .00 | 0 |
2022-12-01 | Zamiri Parisa (Chief Medical Officer) | Option Ex | 9,375 | .00 | 0 |
2022-12-01 | Breuil Robert S (Chief Financial Officer) | Option Ex | 9,938 | .00 | 0 |
2022-11-24 | Guerard Frederic (Chief Executive Officer) | Option Ex | 65,625 | .00 | 0 |
2022-11-24 | Zamiri Parisa (Chief Medical Officer) | Option Ex | 28,125 | .00 | 0 |
2022-11-24 | Breuil Robert S (Chief Financial Officer) | Option Ex | 28,125 | .00 | 0 |
2022-09-04 | Breuil Robert S (Chief Financial Officer) | Option Ex | 10,000 | .00 | 0 |
2022-06-09 | Breuil Robert S (Chief Financial Officer) | Option Ex | 5,000 | .00 | 0 |
2022-05-19 | Guerard Frederic (Chief Executive Officer) | Option Ex | 112,500 | .00 | 0 |
2022-05-19 | Zamiri Parisa (Chief Medical Officer) | Option Ex | 37,500 | .00 | 0 |
2022-05-19 | Breuil Robert S (Chief Financial Officer) | Option Ex | 39,750 | .00 | 0 |
2022-03-31 | Breuil Robert S (Chief Financial Officer) | Sale | 2,188 | 1.25 | 2,735 |
2022-03-31 | Breuil Robert S (Chief Financial Officer) | Option Ex | 5,000 | .00 | 0 |
2021-12-04 | Breuil Robert S (Chief Financial Officer) | Option Ex | 5,000 | .00 | 0 |
2021-09-22 | Breuil Robert S (Chief Financial Officer) | Sale | 7,283 | 3.55 | 25,854 |
2021-09-22 | Breuil Robert S (Chief Financial Officer) | Option Ex | 20,000 | .00 | 0 |
2020-09-29 | Deerfield Partners, L.p. | Buy | 1,562,500 | 16.00 | 25,000,000 |
2020-09-29 | Shaffer Christy L (Director) | Buy | 18,750 | 16.00 | 300,000 |
2020-09-29 | Schwarzman Stephen A (10% Owner) | Buy | 250,000 | 16.00 | 4,000,000 |
2020-09-25 | Orbimed Capital Gp Vi Llc (10% Owner) | Buy | 562,500 | 16.00 | 9,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
of CALC listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Calcimedica, Inc. (symbol CALC,
CIK number 1534133) see
the Securities and Exchange Commission (SEC) website.